The EU market accounts for 25% of all global medicines sales, when we break away and become a smaller separate market, companies may very well priorities bigger markets to introduce their medicines into over the UK. The NHS may as a result struggle to access medicines and combined with the drop, in value of the pound against the euro and the dollar what we can access will cost more. The NHS is already struggling to work within its budgets and targets this will make things worse. The NHS must be considered in future Brexit negations, or we may see shortages of medicines in the future.
The UK may see medicine shortages and delays in the introduction of new medicines after Brexit.
by Jackie (née Heneghan) Peck | Jun 12, 2017 | Brexit, NHS
Recent Posts
Testimonials
“This is the pharma cogent course “ronseal” excellent through the whole process”
Cogent Responsible Person, December 2020
Pharmacy Consulting provided us with a very professional and efficient service over a number of extremely busy months. Not only were they flexible to our requirements but also to our workloads, time schedules and finances. Jackie Peck in particular was extremely aware of our needs and outcome requirements. For a small company such as ourselves this was invaluable. At all times Pharmacy Consulting kept us informed of any amendments, changes, monetary matters and as the client we felt it was a ver… Read more
Testimonial from Seago Yachting- Dan Temple
I want to thank you again for your successful presentation made in London to our Pharma Group Europe conference. Your detailed explanations for all the delegates were extremely interesting and enlightening. Our international participants from Germany, Austria, Switzerland and Romania expressed their praise and encouragement. Zdenek Schmittz- Pharma Group Europe
Testimonial from Zdenek Schmittz- Pharma Group Europe
“Very informative and John was able to demonstrate a great knowledge of export. Having already completed Pharmacy Consulting’s GDP training, I was able to understand the content and what John was explaining in regard to export” Anonymous – Rating 9/10
Export Training
“MHRA GDP guidelines are numerous and specific and potentially serious if not followed. The training went through each point in a common sense way, so the guidelines have appeared far more admirable and attainable.” Philip Hodgkinson – Course Rating 10/10
GDP Training
“A very small group (2 of us attending) but this was excellent! Very interactive course, very informative. Gained a lot of information to take away. Thank you very much.” Jane Lytwynchuk – Course Rating 10/10
GDP & RP Training
“Very good overview of GDP requirements which has given me a much better understanding of client requirements for the services and products we supply.” Bill Castle – Course Rating 9/10
GDP Training
“Many thanks to Brain the trainer” Wagdi Moussa – Course Rating 9/10
GDP & RP Training
“Great Presentation, very informative.” Roshni Rutton-Patel – Course Rating 10/10
GDP & RP Training
“I really enjoyed the 3 days training, it has made me think about my new role and how I’m going to apply this knowledge and take it forward.” – January 2021
Cogent Gold Standard Responsible Person Training